Ad is loading...
LYEL
Price
$0.94
Change
+$0.02 (+2.17%)
Updated
Nov 22, 03:20 PM (EDT)
96 days until earnings call
MLYS
Price
$12.45
Change
+$0.58 (+4.89%)
Updated
Nov 22, 03:30 PM (EDT)
Ad is loading...

LYEL vs MLYS

Header iconLYEL vs MLYS Comparison
Open Charts LYEL vs MLYSBanner chart's image
Lyell Immunopharma
Price$0.94
Change+$0.02 (+2.17%)
Volume$700
CapitalizationN/A
Mineralys Therapeutics
Price$12.45
Change+$0.58 (+4.89%)
Volume$300
CapitalizationN/A
LYEL vs MLYS Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LYEL vs. MLYS commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and MLYS is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (LYEL: $0.92 vs. MLYS: $11.87)
Brand notoriety: LYEL and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 88% vs. MLYS: 128%
Market capitalization -- LYEL: $255.93M vs. MLYS: $590.75M
LYEL [@Biotechnology] is valued at $255.93M. MLYS’s [@Biotechnology] market capitalization is $590.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 2 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 2 bullish, 8 bearish.
  • MLYS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -16.67% price change this week, while MLYS (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.97%.

Reported Earning Dates

LYEL is expected to report earnings on Feb 26, 2025.

MLYS is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($591M) has a higher market cap than LYEL($256M). MLYS YTD gains are higher at: 38.023 vs. LYEL (-52.753). MLYS has higher annual earnings (EBITDA): -168.35M vs. LYEL (-197.45M). LYEL has more cash in the bank: 441M vs. MLYS (264M). LYEL has higher revenues than MLYS: LYEL (63K) vs MLYS (0).
LYELMLYSLYEL / MLYS
Capitalization256M591M43%
EBITDA-197.45M-168.35M117%
Gain YTD-52.75338.023-139%
P/E RatioN/AN/A-
Revenue63K0-
Total Cash441M264M167%
Total Debt51.4MN/A-
TECHNICAL ANALYSIS
Technical Analysis
LYELMLYS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 17 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSMTX19.330.38
+2.01%
Jackson Square SMID-Cap Growth Instl
KARIX9.730.12
+1.25%
Kayne Anderson Renewable Infras I
JNBAX10.010.04
+0.40%
JPMorgan Income Builder A
BDOKX10.310.01
+0.10%
iShares MSCI Total Intl Idx K
VTAIX11.97N/A
N/A
Virtus Tactical Allocation I

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-11.01%
VCYT - LYEL
46%
Loosely correlated
-0.66%
NTLA - LYEL
43%
Loosely correlated
+5.18%
RCKT - LYEL
43%
Loosely correlated
-1.92%
PRME - LYEL
42%
Loosely correlated
-0.67%
FATE - LYEL
42%
Loosely correlated
-6.76%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with RXRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-5.79%
RXRX - MLYS
40%
Loosely correlated
-4.80%
ADCT - MLYS
40%
Loosely correlated
-2.02%
PLRX - MLYS
40%
Loosely correlated
+0.94%
PRME - MLYS
40%
Loosely correlated
-0.67%
LYEL - MLYS
39%
Loosely correlated
-11.01%
More